Montreal, May 10, 2023/Businesswire – Patrick Charest, B. Sc., P. Eng., CEO of Aplantex, is pleased to announce the creation of a business partnership with the Montreal offices of Gowling WLG. “As we are progressing with the set-up of our small-scale production line in our Boucherville facilities and look ahead to our first marketing initiatives in the near future, it’s time to align our diverse intellectual property portfolio with our strategic objectives,” Charest explains.

Protecting our intellectual property is a key strategic objective.

Recognized IP expertise

With its long years of experience in patent law, Gowling WLG has a proven roadmap for international protection and enforcement of intellectual property rights in fields including biotechnology, clean technologies, and energy and pharmaceutical industry technologies, and has worked with clients ranging from innovative startups to universities, research institutes and multinational corporations.

“We immediately understood the full significance of Aplantex’s innovations and their potential benefits for the health and well-being of people all over the world. These innovations deserve to be well-protected, and we’re pleased to contribute to that protection through our proven expertise and extensive network of professionals,” says George Elvira, M. Sc., Ph.D., partner and registered patent agent in Canada and the United States for Gowling WLG.

Game-changing innovations

“It’s clear that our innovations are disrupting the field of plant-based active ingredient production and calling many of our competitors’ business models into question,” Patrick Charest explains. “So we need to be able to protect our innovations and defend our rights for the long term in order to maximize the value of our business. We’re fortunate to be able to rely on the valuable services and advice provided by Gowling WLG’s international network of experts.”

FOR MORE INFORMATION

Share : Back to blog